(Q38010560)

26 August 2017

title

Omega-3 fatty acids and inflammatory bowel diseases - a systematic review (English)

1 reference

inflammatory bowel diseases

26 August 2017

0 references

0 references

1 reference

Eduard Cabré

1

1 reference

26 August 2017

Míriam Mañosa

series ordinal

2

1 reference

26 August 2017

Miquel A Gassull

series ordinal

3

1 reference

26 August 2017

publication date

1 June 2012

1 reference

British Journal of Nutrition

26 August 2017

published in

1 reference

26 August 2017

volume

107 Suppl 2

1 reference

26 August 2017

page(s)

S240-52

1 reference

Safety profile of IBD: lymphoma risks

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Partial replacement of dietary (n-6) fatty acids with medium-chain triglycerides decreases the incidence of spontaneous colitis in interleukin-10-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

A comparison of the effects of medium- and long-chain triglycerides on neutrophil stimulation in experimental ileitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Medium-chain triglyceride-rich enteral nutrition is more effective than low-fat enteral nutrition in rat colitis, but is equal in enteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Cellular and physiological effects of medium-chain triglycerides

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Extra-virgin olive oil-enriched diet modulates DSS-colitis-associated colon carcinogenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Linoleic acid, but not oleic acid, upregulates the production of interleukin-8 by human intestinal smooth muscle cells isolated from patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Enteral absorption in man of eicosapentaenoic acid in different chemical forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Essential fatty acid depletion in children with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Treatment with biologic therapies and the risk of cancer in patients with IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Risk factors for opportunistic infections in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

European evidence-based Consensus on the management of ulcerative colitis: Current management

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Inflammatory bowel disease: cause and immunobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Recent trends in the epidemiology of inflammatory bowel diseases: up or down?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Enteral diets enriched with medium-chain triglycerides and N-3 fatty acids prevent chemically induced experimental colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Dietary Supplementation with Fish Oil in Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Dietary fat attenuates the benefits of an elemental diet in active Crohn's disease: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: a pilot study comparing seal oil and cod liver oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Lipoxins and resolvins in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Fatty acids and immune function: relevance to inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Polymeric Diet Alone Versus Corticosteroids in the Treatment of Active Pediatric Crohn’s Disease: A Randomized Controlled Open-Label Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Effect of low- and high-fat, peptide-based diets on body composition and disease activity in adolescents with active Crohn's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Reversal of altered intestinal mucosal immunity in rats fed elemental diet by supplementation of oleic acid

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Association of n-3 and n-6 long-chain polyunsaturated fatty acids in plasma lipid classes with inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

N-3 polyunsaturated fatty acid diet therapy for patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Serum n3 polyunsaturated fatty acids are depleted in Crohn's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Treatment of ulcerative colitis with fish oil n--3-omega-fatty acid: an open trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Changes in mucosal fatty acid profile in inflammatorybowel disease and in experimental colitis: a common response to bowel inflammation

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Impact of enteral supplements enriched with omega-3 fatty acids and/or omega-6 fatty acids, arginine and ribonucleic acid compounds on leptin levels and nutritional status in active Crohn's disease treated with prednisolone

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease--a randomized, placebo-controlled, double-blind cross-over trial

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Distal procto-colitis, natural cytotoxicity, and essential fatty acids

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

n-3 fatty acids only delay early relapse of ulcerative colitis in remission

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

High-dose fish oil and antioxidants in Crohn's disease and the response of bone turnover: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Comparison of omega-3 fatty acids and sulfasalazine in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Medium-chain triglycerides modulate ileitis induced by trinitrobenzene sulfonic acid.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

Therapeutic potential of fish oil in the treatment of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001626

7 January 2021

10.1017/S0007114512001626

Identifiers

DOI

1 reference

26 August 2017

1 reference